We're all set for a new experience. To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
AskQtyOrders

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

1,159.703 days ago
1,210.503 days ago
arrow

LOWER/UPPER CIRCUITS

1,080.50
1,320.50
arrow
Dr Reddys Laboratories Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral

Our researchers has found no immediate positive insights for this stock. We'll update this space as soon as we find something.

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 17.24%
Net profit growth 5Y CAGR : 23.89%

STOCK RETURNS

info
Versus Nifty 50
1 w
+1.93%
vs
+2%
1 mth
-2.01%
vs
+2.83%
3 mth
-3.14%
vs
+5.36%
6 mth
-9.92%
vs
-0.29%
1 yr
-0.35%
vs
+8.6%
3 yr
+41.43%
vs
+41.68%
5 yr
+48.15%
vs
+165.76%
Dr Reddys Laboratories Ltd Top mutual funds holding
arrow
Dr. Reddy’s Laboratories Limited commenced its generics business in India in 1986 and is currently a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality, affordable and innovative medicines across therapy areas. The company is a leading India-based pharmaceutical company headquartered and having its registered office in Hyderabad, Telangana, India. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations.
personal

Grow your wealth with more research recommendations

+91